Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases

International Journal of Oncology

Volumn 46, Issue 4, 2015, Pages 1582-1588

  Jing, Feifeng ^a   Kim, Hun Jin ^a   Kim, Chang Hyun ^a   Kim, Young Jin ^a   Lee, Jae Hyuk ^b   Kim, Hyeong Rok ^a  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Cancer stem cell markers; CD133; CD44; Colorectal carcinoma; Hepatic metastasis

Indexed keywords

CD133 ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERMES ANTIGEN; MESSENGER RNA; CD44 PROTEIN, HUMAN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STEM CELL; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LYMPH VESSEL METASTASIS; MALE; PERINEURAL INVASION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; AGED; COLORECTAL TUMOR; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; PROGNOSIS; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD44; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84923071598     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2844     Document Type: Article

References (50)

1. SIEGEL R, NAISHADHAM D and JEMAL A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. SAKAI Y: Current topics in colorectal liver metastasis. Int J Clin Oncol 16: 451-451, 2011.
3. VAN CUTSEM E, LAMBRECHTS D, PRENEN H, JAIN RK and CARMELIET P: Lessons from the adjuvant bevacizumab trial on colon cancer: What next? J Clin Oncol 29: 1-4, 2011.
4. HUANG X, SHENG Y and GUAN M: Co-expression of stem Cell genes CD133 and CD44 in colorectal cancers with early liver metastasis. Surg Oncol 21: 103-107, 2012.
5. GALIZIA G, GEMEI M, DEL VECCHIO L, et al: Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. Arch Surg 147: 18-24, 2012.
6. ANDERSON EC, HESSMAN C, LEVIN TG, MONROE MM and WONG MH: The role of colorectal Cancer stem cells in metastatic disease and therapeutic response. Cancers (Basel) 3: 319-339, 2011.
7. HU Y and FU L: Targeting Cancer stem cells: A new therapy to cure Cancer patients. Am J Cancer Res 2: 340-356, 2012.
8. YU ZR, PESTELL TG, LISANTI MP and PESTELL RG: Cancer stem cells. Int J Biochem Cell Biol 44: 2144-2151, 2012.
9. SOLTANIAN S and MATIN MM: Cancer stem cells and Cancer therapy. Tumour Biol 32: 425-440, 2011.
10. WAKAMATSU Y, SAKAMOTO N, OO HZ, NAITO Y, URAOKA N, ANAMI K, SENTANI K, OUE N and YASUI W: Expression of Cancer stem Cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int 62: 112-119, 2012.
11. BENDARDAF R, ALGARS A, ELZAGHEID A, KORKEILA E, RISTAMAKI R, LAMLUM H, COLLAN Y, SYRJANEN K and PYRHONEN S: Comparison of CD44 expression in primary tumours and metastases of colorectal cancer. Oncol Rep 16: 741-746, 2006.
12. BIRD NC, MANGNALL D and MAJEED AW: Biology of colorectal liver metastases: A review. J Surg Oncol 94: 68-80, 2006.
13. JAGGUPILLI A and ELKORD E: Signifcance of CD44 and CD24 as Cancer stem Cell markers: An enduring ambiguity. Clin Dev Immunol: May 30, 2012. doi: 10.1155/2012/708036.
14. DALERBA P, DYLLA SJ, PARK IK, et al: Phenotypic characterization of human colorectal Cancer stem cells. Proc Natl Acad Sci USA 104: 10158-10163, 2012.
15. SU YJ, LAI HM, CHANG YW, CHEN GY and LEE JL: Direct repro-gramming of stem Cell properties in colon Cancer cells by CD44. EMBO J 30: 3186-3199, 2011.
16. RICCI-VITIANI L, LOMBARDI DG, PILOZZI E, BIFFONI M, TODARO M, PESCHLE C and DE MARIA R: Identification and expansion of human colon cancer-initiating cells. Nature 445: 111-115, 2007.
17. + population effciently enriches colon Cancer initiating cells. Ann Surg Oncol 15: 2927-2933, 2008.
18. O'BRIEN CA, POLLETT A, GALLINGER S and DICK JE: A human colon Cancer Cell capable of initiating tumour growth in immunodef-cient mice. Nature 445: 106-110, 2007.
19. BAO SD, WU QL, MCLENDON RE, HAO YL, SHI Q, HJELMELAND AB, DEWHIRST MW, BIGNER DD and RICH JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006.
20. FRANK NY, PENDSE SS, LAPCHAK PH, MARGARYAN A, SHLAIN D, DOEING C, SAYEGH MH and FRANK MH: Regulation of progenitor Cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 278: 47156-47165, 2003
21. FRANK NY, MARGARYAN A, HUANG Y, SCHATTON T, WAAGA-GASSER AM, GASSER M, SAYEGH MH, SADEE W and FRANK MH: ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65: 4320-4333, 2005.
22. HORST D, KRIEGL L, ENGEL J, KIRCHNER T and JUNG A: Prognostic signifcance of the Cancer stem Cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest 27: 844-850, 2009.
23. SAIGUSA S, TANAKA K, TOIYAMA Y, YOKOE T, OKUGAWA Y, IOUE Y, MIKI C and KUSUNOKI M: Correlation of CD133, OCT4, and SOX2 in rectal Cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol 16: 3488-3498, 2009.
24. BOTCHKINA IL, ROWEHL RA, RIVADENEIRA DE, KARPEH MS Jr, CRAWFORD H, DUFOUR A, JU J, WANG Y, LEYFMAN Y and BOTCHKINA GI: Phenotypic subpopulations of metastatic colon Cancer stem cells: Genomic analysis. Cancer Genomics Proteomics 6: 19-29, 2009.
25. BOTCHKINA GI, ZUNIGA ES, DAS M, EL AL: New-generation taxoid SB-T-1214 inhibits stem cell-related Gene expression in 3D Cancer spheroids induced by purifed colon tumor-initiating cells. Mol Cancer 9: 192, 2010. doi: 10.1186/1476-4598-9-192.
26. CHEN KL, PAN F, JIANG H, CHEN JF, PEI L, XIE FW and LIANG HJ: Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+) CD44(high) metastatic subset in HCT116 colon Cancer cells. Clin Exp Metastasis 28: 751-763, 2011.
27. NAGATA T, SAKAKURA C, KOMIYAMA S, et al: Expression of Cancer stem Cell markers CD133 and CD44 in locoregional recurrence of rectal cancer. Anticancer Res 31: 495-500, 2011.
28. +/high tumor cells in hematogenous metastasis of liver cancers. Cell Res 22: 259-272, 2012.
29. + in human colon Cancer and liver metastasis. J Cell Physiol 228: 408-415, 2013.
30. HUH J W, KIM HR, KIM YJ, LEE JH, PARK YS, CHO SH and JOO JK: Expression of standard CD44 in human colorectal carcinoma: Association with prognosis. Pathol Int 59: 241-246, 2009.
31. OHJI Y, YAO T, EGUCHI T, YAMADA T, HIRAHASHI M, IIDA M and TSUNEYOSHI M: Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: Multivariate analysis of clinico-pathological and mmunohistochemical factors. Oncol Rep 17: 525-530, 2007.
32. PARK JJ, KWON JH, OH SH, et al: Differential expression of CD133 based on microsatellite instability status in human colorectal cancer. Mol Carcinog 53: E1-E10, 2014.
33. JONES RJ: Cancer stem cells-clinical relevance. J Mol Med (Berl) 87: 1105-1110, 2009.
34. PAPAILIOU J, BRAMIS KJ, GAZOULI M and THEODOROPOULOS G: Stem cells in colon cancer. A new era in Cancer theory begins. Int J Colorectal Dis 26: 1-11, 2011.
35. BAUMANN M, KRAUSE M and HILL R: Exploring the role of Cancer stem cells in radioresistance. Nat Rev Cancer 8: 545-554, 2008.
36. EYLER CE and RICH JN: Survival of the fttest: Cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 26: 2839-2845, 2008.
37. FRANK NY, SCHATTON T and FRANK MH: The therapeutic promise of the Cancer stem Cell concept. J Clin Invest 120: 41-50, 2010.
38. LI M, LI JY, ZHAO AL and GU J: Colorectal Cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology 73: 52-57, 2007.
39. CHUNG CK, ZAINO RJ and STRYKER JA: Colorectal carcinoma: Evaluation of histologic grade and factors infuencing prognosis. J Surg Oncol 21: 143-148, 1982.
40. UMPLEBY HC, BRISTOL JB, RAINEY JB and WILLIAMSON RC: Survival of 727 patients with single carcinomas of the large bowel. Dis Colon Rectum 27: 803-810, 1984.
41. KAZAMA Y, WATANABE T, KANAZAWA T, TANAKA J, TANAKA T and NAGAWA H: Poorly differentiated colorectal adenocarcinomas show higher rates of microsatellite instability and promoter methylation of p16 and hMLH1: A study matched for T classifca-tion and tumor location. J Surg Oncol 97: 278-283, 2008.
42. MULDER JW, KRUYT PM, SEWNATH M, OOSTING J, SELDENRIJK CA, WEIDEMA WF, OFFERHAUS GJ and PALS ST: Colorectal Cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344: 1470-1472, 1994.
43. WEG-REMERS S, ANDERS M, VON LAMPE B, RIECKEN EO, SCHUDER G, FEIFEL G, ZEITZ M and STALLMACH A: Decreased expression of CD44 splicing variants in advanced colorectal carcinomas. Eur J Cancer 34: 1607-1611, 1998.
44. LUGLI A, IEZZI G, HOSTETTLER I, MURARO MG, MELE V, TORNILLO L, CARAFA V, SPAGNOLI G, TERRACCIANO L and ZLOBEC I: Prognostic impact of the expression of putative Cancer stem Cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 103: 382-390, 2010.
45. HORST D, KRIEGL L, ENGEL J, KIRCHNER T and JUNG A: CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 99: 1285-1289, 2008.
46. KOJIMA M, ISHII G, ATSUMI N, FUJII S, SAITO N and OCHIAI A: Imunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study. Cancer Sci 99: 1578-1583, 2008.
47. LI CY, LI BX, LIANG Y, et al: Higher percentage of CD133(+) cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med 7: 56, 2009. doi: 10.1186/1479-5876-7-56.
48. CHOI D, LEE HW, HUR KY, KIM JL, PARK GS, JANG SH, SONG YS, LANG KS and PAIK SS: Cancer stem Cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 15: 2258-2264, 2009.
49. HUH JW, PARK YS, LEE JH, KIM HR, SHIN MG and KIM YJ: CD133 mRNA expression and microsatellite instability in colorectal carcinoma. J Surg Oncol 102: 765-770, 2010.
50. ZLOBEC I, TERRACCIANO L, JASS JR and LUGLI A: Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Virchows Arch 451: 763-769, 2007.